Since the anti-CD20 monoclonal antibody rituximab (Rituxan; Genentech) was introduced about 20 years ago to treat follicular ...

Administer Rituxan Hycela as a single-agent every 8 weeks for 12 doses. Non-progressing FL after first-line CVP chemotherapy: 1400mg/23400 Units over 5mins once weekly for 3 weeks at 6-month ...

After Suzanne Morphew’s remains were found in 2023, an autopsy determined Morphew died by homicide with several drugs in her ...

The FDA approved the first monoclonal antibody, Rituxan, in 1998 for treatment of lymphomas that failed conventional chemotherapy. Oncologists, excited by promising early data, quickly embraced ...

Rituximab (Rituxan or Truxima) is another biologic that you can try if other drugs haven't helped you. These types of drugs are designed to suppress your immune system if you have a serious form ...

In the preceding three months, 27 analysts have released ratings for Biogen (NASDAQ:BIIB), presenting a wide array of ...

Adding Calquence to standard-of-care chemoimmunotherapy improved progression-free survival in patients with previously ...

ALX Oncology Holdings Inc. ALXO reported positive results from an ongoing phase I/II investigator-sponsored study of evorpacept, in combination with Roche’s RHHBY Rituxan (rituximab) and Bristol ...

Higher yields, improved media, and perfusion are driving network optimization at Roche and led to the recent divestment of a ...

Truxima is a biosimilar drug. It’s based on the parent drug Rituxan. Keep reading for specific information about the dosage of Truxima, including its strength and how to receive the medication.

Deep-pocketed investors have adopted a bearish approach towards Biogen BIIB, and it's something market players shouldn't ...